Invenomic Fund Investor Class’s (BIVRX) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Invenomic Fund Investor Class is a Sell.
Invenomic Fund Investor Class’s (BIVRX) 20-Day exponential moving average is 16.79, making it a Buy.
Invenomic Fund Investor Class’s (BIVRX) 50-Day exponential moving average is 16.76, making it a Buy.
Invenomic Fund Investor Class (BIVRX) Pivot Points
Aug 20, 2025, 05:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.25
17.25
17.25
17.25
17.25
17.25
17.25
Fibonacci
17.25
17.25
17.25
17.25
17.25
17.25
17.25
Invenomic Fund Investor Class (BIVRX) Moving Averages
Aug 20, 2025, 05:26 AM
Period
Simple
Exponential
MA5
17.02Buy
17.05Buy
MA10
16.71Buy
16.87Buy
MA20
16.79Buy
16.79Buy
MA50
16.76Buy
16.76Buy
MA100
16.74Buy
16.76Buy
MA200
16.76Buy
16.72Buy
Invenomic Fund Investor Class’s (BIVRX) 10-Day exponential moving average is 16.87, making it a Buy.
Invenomic Fund Investor Class’s (BIVRX) 100-Day exponential moving average is 16.76, making it a Buy.
Invenomic Fund Investor Class’s (BIVRX) 50-day simple moving average is 16.76, creating a Buy signal.
Invenomic Fund Investor Class’s (BIVRX) 100-day simple moving average is 16.74, creating a Buy signal.
Invenomic Fund Investor Class’s (BIVRX) 200-day simple moving average is 16.76, creating a Buy signal.
Invenomic Fund Investor Class (BIVRX) Technical Analysis
Aug 20, 2025, 05:26 AM
Name
Value
Action
RSI (14)
62.93
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
0.07
Sell
ADX (14)
17.11
Buy
Williams %R
0.00
-
CCI (14)
86.43
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
72.92
Buy
ROC
1.83
Buy
Invenomic Fund Investor Class’s (BIVRX) Relative Strength Index (RSI) is 62.93, creating a Neutral signal.
Invenomic Fund Investor Class’s (BIVRX) Trend Strength Indicator (ADX) is 17.11, creating a Buy signal.
Invenomic Fund Investor Class’s (BIVRX) Commodity Channel Index (CCI) is 86.43, creating a Neutral signal.
Invenomic Fund Investor Class’s (BIVRX) Price Rate of Change (ROC) is 1.83, creating a Buy signal.